Can Quercetin protect against the pre-disposing factors for Alzheimer’s disease via inhibiting NLRP3 inflammasome pathway?
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Azza S Awad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy (Girls), Al-Azhar University, Nasr city, Cairo, Egypt. Hauptthemen laut MEDLINE: Quercetin, Alzheimer Disease, NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Objectives
The brain and its cognitive functions are most liable to stress, where it is known to promote the pathological manifestation of Alzheimer’s disease (AD). This study aimed to investigate the effect of a 2-week-period of restraint stress (RS), as well as the protective effect of Quercetin in a dose-dependent manner against the early start of AD via studying the NLRP3 inflammasome pathway.
Methods
The rats were divided into four groups: control (Con), induction (Ind), where 6 h/day for 2 weeks of RS was induced, low and high doses of Q (Q1+Ind and Q2+Ind, respectively), which were administered before the induction of RS for the same period. Behavioral tests were performed to assess the cognitive functions. Key findings The higher dose of Q has shown more inhibition of the NLRP3 inflammasome pathway, oxidative stress, as well as the phosphorylated-tau and amyloid-β (Aβ) protein, which were significantly fired up by the 2 weeks of RS. These results were backed with the improved cellular structure in the histopathological examination and enhanced cognitive functions, where the two doses of Q have shown their protective effect.
Conclusions
This proves that Q shielded the brain against the initial pathogenesis of AD, induced by 2 weeks of RS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy (Girls), Al-Azhar University, Nasr city, Cairo, Egypt.
- Faculty of Pharmacy, Ahram Canadian University, Egypt.
- Egyptian Drug Authority (EDA), Egypt.
ORCID-Profile: Azza S Awad
Zitieren
APA
Awad, A. S., El-Mokadem, B. M., Sherif, M. M., & Bishr, A. (2025). Can Quercetin protect against the pre-disposing factors for Alzheimer’s disease via inhibiting NLRP3 inflammasome pathway?. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf020
Vancouver
Awad AS, El-Mokadem BM, Sherif MM, Bishr A. Can Quercetin protect against the pre-disposing factors for Alzheimer’s disease via inhibiting NLRP3 inflammasome pathway?. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf020
BibTeX
@article{Awad2025,
author = {Awad, Azza S and El-Mokadem, Bassant M and Sherif, Miar M and Bishr, Abeer},
title = {Can Quercetin protect against the pre-disposing factors for Alzheimer’s disease via inhibiting NLRP3 inflammasome pathway?},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf020}
}
EUVIMED